icn pharmaceut lticn seek acquisit icn pharmaceut ha 500 mln dlr cash anoth 150 billion dlr avail credit intend buy pharmaceut compani chairman milan panic compani annual meet acquisit place 24 month compani ha nearli billion dlr avail acquisit today panic ad investig number compani compani studi possibl acquir friendli basi panic intend seek board approv today repurchas mln icn common share discuss possibl acquisit panic purchas necessari becaus icn current market capabl suffici support distribut compani product icn expect market growth worldwid icn princip product ribavirin virazol drug market number countri describ broadbas antivir compani ha possibl applic includ treatment type hepat herp influenza childhood diseas hemorrhag fever icn ha focu consir investor attent recent month becaus virazol ha undergon clinic trial possibl treatment aidsrel diseas panic today discuss drug regard aid food drug administr complet review data submit compani investig drug conduct hous subcommitte continu subcommitte fda acknowledg conduct separ investig determin icn witheld data fda advers reaction drug virazol approv market aerosol form treatment infect strike infant call respiratori syncyti viru